1.
Heidenreich
PA
,
Bozkurt
B
,
Aguilar
D
,
Allen
LA
,
Byun
JJ
,
Colvin
MM
, et al
.
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
.
Circulation
.
2022
;
145
(
18
):
e895
1032
.
2.
Abassi
Z
,
Khoury
EE
,
Karram
T
,
Aronson
D
.
Edema formation in congestive heart failure and the underlying mechanisms
.
Front Cardiovasc Med
.
2022
;
9
:
933215
.
3.
Peters
AE
,
Mentz
RJ
,
DeWald
TA
,
Greene
SJ
.
An evaluation of torsemide in patients with heart failure and renal disease
.
Expert Rev Cardiovasc Ther
.
2022
;
20
(
1
):
5
11
.
4.
Wu
L
,
Rodriguez
M
,
El Hachem
K
,
Krittanawong
C
.
Diuretic treatment in heart failure: a practical guide for clinicians
.
J Clin Med
.
2024
;
13
(
15
):
4470
.
5.
Welzel
B
,
Schmidt
R
,
Kirchhoff
L
,
Gramer
M
,
Löscher
W
.
The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia
.
Epilepsy Behav
.
2023
;
139
:
109057
.
6.
Lo
KB
,
Rangaswami
J
.
Torsemide is a more appropriate oral loop diuretic for patients with heart failure: CON
.
Kidney360
.
2024
;
5
(
8
):
1069
71
.
7.
Buggey
J
,
Mentz
RJ
,
Pitt
B
,
Eisenstein
EL
,
Anstrom
KJ
,
Velazquez
EJ
, et al
.
A reappraisal of loop diuretic choice in heart failure patients
.
Am Heart J
.
2015
;
169
(
3
):
323
33
.
8.
Kasama
S
,
Toyama
T
,
Hatori
T
,
Sumino
H
,
Kumakura
H
,
Takayama
Y
, et al
.
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure
.
Heart
.
2006
;
92
(
10
):
1434
40
.
9.
Singh
S
,
Goel
S
,
Duhan
S
,
Chaudhary
R
,
Garg
A
,
Tantry
US
, et al
.
Effect of furosemide versus torsemide on hospitalizations and mortality in patients with heart failure: a meta-analysis of randomized controlled trials
.
Am J Cardiol
.
2023
;
206
:
42
8
.
10.
Teixeira
L
,
Felix
N
,
Navalha
DDP
,
Ferreira
R
,
Clemente
MRC
,
Madeira
T
, et al
.
Torsemide versus furosemide in the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials
.
Arq Bras Cardiol
.
2024
;
121
(
6
):
e20230825
.
11.
Mentz
RJ
,
Anstrom
KJ
,
Eisenstein
EL
,
Sapp
S
,
Greene
SJ
,
Morgan
S
, et al
.
Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial
.
JAMA
.
2023
;
329
(
3
):
214
23
.
12.
Kido
K
,
Al-Mamun
M
.
Evaluation of patients with heart failure with reduced ejection fraction treated with bumetanide versus torsemide
.
Cardiology
.
2025
:
1
17
.
You do not currently have access to this content.